Walleye Capital
BIO icon

Walleye Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Walleye Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,400
Closed -$1.2M – 5305
2024
Q2 		$1.2M Buy
4,400
+4,100
+1,367% +$1.19M 0.01% 2644
2024
Q1 		$104K Sell
300
-1,700
-85% -$559K ﹤0.01% 4376
2023
Q4 		$646K Buy
+2,000
New +$627K 0.01% 2737
2020
Q1 		– Sell
-400
Closed -$148K – 987
2019
Q4 		$148K Sell
400
-1,100
-73% -$388K 0.03% 1243
2019
Q3 		$499K Sell
1,500
-6,500
-81% -$2.12M 0.33% 755
2019
Q2 		$2.5M Buy
+8,000
New +$2.4M 2.44% 64

Other funds holding BIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $18.8B AUM 17.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return